Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective.

Nava Siegelmann-DanieliItzhak KatzirJanet Vesterman LandesYaakov SegalRachel BacharHadas Rotem RabinovichMartin BialikJoseph AzuriAvi PorathYossef Lomnicky

Published in: Breast cancer research and treatment (2017)

In peri-menopausal women, LNG-IUS was not associated with an increased total risk of BC, although in the subgroup of women in their early 40's, it was associated with a slightly increased risk for invasive tumors.

Keyphrases

breast cancer risk
polycystic ovary syndrome
pregnancy outcomes
cervical cancer screening
insulin resistance
randomized controlled trial
clinical trial
metabolic syndrome
study protocol